当前位置: 首页 > 期刊 > 《《食品与药品·A版》》 > 2008年第5期
编号:11754341
冬凌草甲素、乙素的研究进展
http://www.100md.com 2008年5月1日 《食品与药品·A版》 2008年第5期
     摘要:冬凌草甲素、乙素具有多种药理作用,尤其是抗癌活性。本文通过分析近年国内外发表的文献,综述冬凌草甲素、乙素的提取、分离、药理、制剂、药动学等。冬凌草甲素、乙素的药用价值值得进一步研究,应更深层次地开发利用。

    关键词:冬凌草甲素、乙素;提取;分离;抗癌作用;制剂;药动学

    中图分类号:R284文献标识码:A文章编号:1672-979X(2008)09-0072-04

    Progress on Rubescensine A and B

    DAI Yi, SUN Long-ru

    (School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China)

    Abstract:Rubescensine A and B have many pharmacological actions, especially anticancer activity. This paper reviews the latest research status of rubescensine A and B by collecting and analyzing literature from many countries, including extraction, separation, pharmacological action, pharmaceutical preparation and pharmacokinetic. The medicinal value of rubescensine A and B is worth being further investigated.

    Key words:rubescensine A and B; extraction; separation; anticancer effect; pharmaceutical preparation; pharmacokinetic

    冬凌草甲素、乙素是唇形科(Labiatae)香茶菜属(Rabdosia)植物中的2种重要活性二萜成分 ......

您现在查看是摘要页,全文长 4626 字符